We also report for the first time that among controls with the A*/A* GSTA1 genotype, ever smokers had lower odds of having detectable PAH–DNA adducts than did never smokers with the same genotype (OR, 0.62; 95% CI, 0.41–0.92). The gene discussed is GSTA1; the disease is pulmonary arterial hypertension.